Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 7, 2026Open Access

Myasthenia Gravis: Bridging Pathophysiology with Precision and Targeted Therapies

View Full Paper
Ask AI
Bookmark
Share

Authors

KPKhushi PandeySTSakshi Tyagi

Discussion

Loading...

Member takes

Overview

Review reveals treatment advancements in myasthenia gravis, suggesting effective management and better patient care.

Key Points

  • To provide a comprehensive overview of myasthenia gravis, highlighting pathophysiology and advancements in treatment.
  • Review of clinical features, diagnostic strategies, and therapeutic developments in myasthenia gravis.
  • Advanced therapies like monoclonal antibodies significantly improve outcomes in refractory cases.
  • Emerging treatments such as gene therapy and targeted biologics show promise for personalized care.

Cite This Study

Pandey et al. (2026) studied this question.

synapsesocial.com/papers/69fbefc0164b5133a91a3ae4https://doi.org/10.5281/zenodo.20033739
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Myasthenia Gravis: Bridging Pathophysiology with Precision and Targeted Therapies2026
  2. 2Myasthenia gravis: innovative therapies and new frontiers in research2026
  3. 3Reimagining Myasthenia Gravis Care: Current Strategies and New Developments2024
  4. 4Advances in Understanding and Managing Myasthenia Gravis: Current Trends and Future Directions2024 · 2 citations
  5. 5ADVANCES IN THE DIAGNOSIS AND MANAGEMENT OF MYASTHENIA GRAVIS2026